Updated Jul 16, 2026
McCulloch Kevin has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $723K.

| Role | See Remarks |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | XERS | Xeris Biopharma Holdings, Inc. | S — Open-market sale | 90.0K | $8.03 | $723K |
| 2026-03-16 | XERS | Xeris Biopharma Holdings, Inc. | M — Option exercise | 4 | $3.94 | $16 |
| 2026-03-16 | XERS | Xeris Biopharma Holdings, Inc. | M — Option exercise | 48.9K | $4.09 | $200K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 27.3K | $7.36 | $201K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 30.3K | $7.36 | $223K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 68.5K | $7.36 | $504K |
| 2026-02-02 | XERS | Xeris Biopharma Holdings, Inc. | A — Grant or award | 168.5K | $0.00 | |
| 2025-10-02 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 733 | $8.31 | $6K |
| 2025-09-11 | XERS | Xeris Biopharma Holdings, Inc. | J — Other acquisition / disposition | 2.0K | $0.00 | |
| 2025-08-01 | XERS | Xeris Biopharma Holdings, Inc. | F — Tax withholding / forfeiture | 14.7K | $5.38 | $79K |
McCulloch Kevin is a corporate insider — currently tracked as See Remarks of Xeris Biopharma Holdings, Inc. (XERS). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($723K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live McCulloch Kevin profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.